<DOC>
	<DOCNO>NCT02367131</DOCNO>
	<brief_summary>Study investigate safety efficacy daily use JARDIANCE速 Tablets Japanese elderly patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Daily Use JARDIANCE速 Tablets Japanese Elderly Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : Male female elderly patient ( age 65 ) type 2 diabetes mellitus never treat JARDIANCE速 Tablets enrolment start take JARDIANCE速 Tablets within 3 month launch Japan Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>